A thorough investigation of HDAC gene expression in MDS and AML showed that in myeloid malignancies, HDAC expression is heterogenous, with no clear pattern of over- or under-expression of any HDAC [37]. Here, HDAC9 is linked to myelodysplastic syndrome.